Interferon alfa-2b XL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interferon alfa-2b XL, covering 2013-09-20 to 2013-09-20. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4 [Phase 2]